Featured White Papers
- Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
- PCI DSS therapy for the smaller retailer (McAfee)
- The rise of Web commuting (Citrix Online)
Technology Industry
Industry: Email Alert RSS FeedLet's be careful
Science News, Sept 1, 2007 by Kenneth Timoner
"Crossing the Line: Technique could treat brain diseases" (SN: 6/23/07, p. 387) describes attaching a drug molecule to a molecule from the rabies virus that enables the drug to cross the blood-brain barrier. This suggests a possible danger if the ability to produce the molecule could be transferred to the genomes of disease organisms in the wild. If the field of genetic engineering for drug production doesn't already have guidelines to cover such risks, now might be the time to develop them.
KENNETH TIMONER, EDINA, MINN.
COPYRIGHT 2007 Science Service, Inc.
COPYRIGHT 2008 Gale, Cengage Learning